MindFreedom International’s Correspondence with Pfizer

In 2004, MindFreedom challenged pharmaceutical giant Pfizer to produce evidence of the chemical imbalance its drugs were advertised to correct. This folder contains a record of the correspondence that took place.

File 9 December 2003 – Letter from David Oaks to the FCC, FDA and FTC
9 December 2003 – This letter is an official complaint regarding Pfizer’s deceptive advertising for Zoloft.
File 9 December 2003 – Letter from David Oaks to Frank Raines, CEO of Fanny Mae
9 December 2003 – In this letter, David Oaks requests that Frank Raines, a board member of Pfizer and CEO of Fanny Mae, respond to the charge that Pfizer is deceiving consumers with its advertisements for Zoloft.
File 11 March 2004 – Letter from MFI Panel to Pfizer Vice President Dr. Cathryn Clary
This letter from MindFreedom’s scientific panel addresses Pfizer’s failure to provide evidence to support their claim of a chemical imbalance in the brain.
File 16 April 2004 – Letter to FCC, FDA, and FTC
This is a letter from David Oaks to the FCC, FDA, and FTC, addressing the unsupported claims of a chemical imbalance in the brain made by Pfizer in their advertisements for the drug Zoloft.
File 16 April 2004 – Letter from David Oaks to Pfizer Vice President Dr. Cathryn Clary
This letter by David Oaks is a reply to Pfizer’s response to a request for evidence supporting their claim that a chemical imbalance in the brain underlies major depressive disorder.
File 16 April 2004 – Letter of understanding from David Oaks to Hank McKinnell, Ph.D.
This is a letter of understanding from David Oaks to Hank McKinnell, Ph.D., Chairman and CEO of Pfizer. It requests that Pfizer provide evidence to the contrary if they wish to contest the claim that they have been unable to provide any peer-reviewed scientific evidence that Zoloft corrects a chemical imbalance in the brain.
File 16 April 2004 – Letter to Frank Raines, CEO of Fannie Mae
16 April 2004 – A letter from David Oaks to Frank Raines, CEO of Fannie Mae. It requests that, on the basis of Pfizer’s inability to provide peer-reviewed evidence of the claim that Zoloft corrects a chemical imbalance in the brain, action be taken to restrain that company’s fraudulent advertising.
File 16 April 2004 – Letter to Dr. Cathryn Clary from MFI’s Scientific Panel
16 April 2004 – This is the letter from MindFreedom’s Scientific Panel to Dr. Cathryn Clary, contesting Pfizer’s response to a request for evidence that Zoloft corrects a chemical imbalance in the brain.
Folder 17 February 2004 – Letter from Dr. Cathryn Clary to David Oaks
17 February 2004 – This folder contains scans of the two page letter sent by Dr. Cathryn Clary of Pfizer to David Oaks in response to his request for peer-reviewed evidence of the claim that Zoloft corrects a chemical imbalance in the brain.
File 19 April 2004 – Letter from David Oaks to Representative Peter DeFazio
19 April 2004 – This is a letter from David Oaks to Representative Peter DeFazio (D – OR) requesting action be taken to stop Pfizer from continuing to use fraudulent claims in their advertisements for Zoloft.
File 19 April 2004 – Letter from David Oaks to Senator Gordon Smith
19 April 2004 – This is a letter from David Oaks to Senator Gordon Smith (R – OR) requesting action be taken to stop Pfizer from continuing to use fraudulent claims in their advertisements for Zoloft.
File 19 April 2004 – Letter from David Oaks to Senator Ron Wyden
19 April 2004 – This is a letter from David Oaks to Senator Ron Wyden (D – OR) requesting action be taken to stop Pfizer from continuing to use fraudulent claims in their advertisements for Zoloft.
File 20 September 2004 – Letter from David Oaks to Dr. Cathryn Clary
20 September 2004 – This is a letter from David Oaks to Dr. Cathryn Clary, informing her of the requests being made for a congressional investigation.
File 20 September 2004 – Letter from David Oaks to the Pfizer Board of Directors
20 September 2004 – This is a letter from David Oaks to Pfizer’s Board of Directors, requesting that they halt the use of unsubstantiated claims in their advertisements for Zoloft.
File 20 September 2004 – Letter from the Scientific Panel to Dr. Cathryn Clary
20 September 2004 – This is a letter from the Scientific Panel to Dr. Cathryn Clary, disputing points made in her reply to a request for peer-reviewed evidence of the claim that Zoloft corrects a chemical imbalance in the brain.
File 22 September 2004 – Letter from David Oaks to the FCC, FDA, and FTC
22 September 2004 – This is a letter from David Oaks to the FCC, FDA, and FTC informing them that, due to their inaction, a Congressional investigation is being sought.
File 22 September 2004 – Letter from David Oaks to Frank Raines, CEO of Fannie Mae
22 September 2004 – This is a letter from David Oaks to Frank Raines, CEO of Fannie Mae, expressing his disappointment in Pfizer’s refusal to halt the use of fraudulent claims in their advertisements for Zoloft.
File 25 April 2006 – Letter from David Boyer to David Oaks
25 April 2006 – This is a letter from David W. Boyer, Assistant Commisioner for Legislation, to David Oaks, written at the request of Senator Ron Wyden (D – OR).

Document Actions